Page last updated: 2024-10-28

phenelzine and Dyskinesia, Drug-Induced

phenelzine has been researched along with Dyskinesia, Drug-Induced in 2 studies

Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.

Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Morgan, JL1
Brown, TM1
Wallace, ER1
Ashford, JW1
Ford, CV1

Other Studies

2 other studies available for phenelzine and Dyskinesia, Drug-Induced

ArticleYear
Monoamine oxidase inhibitors and sleep movements.
    The American journal of psychiatry, 1994, Volume: 151, Issue:5

    Topics: Adult; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Male; Myoclonus; Phenelzine; P

1994
Use of MAO inhibitors in elderly patients.
    The American journal of psychiatry, 1979, Volume: 136, Issue:11

    Topics: Aged; Depression; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans;

1979